MCM4 and metastatic malignant neoplasm in the lymph nodes: MCM4 was significantly upregulated in LUAD tissues with lymph node metastasis, and in the N2 subgroup, patients with high MCM4 expression had markedly worse FPS outcomes (HR = 4.33, log-rank p = 7.6 × 10−6) (Figure 9A,B).